Completed NA INTERVENTIONAL 2-arm NCT02279121

ATAPAC Study (TauroLock Activity in Adult Cancer Patients) (ATAPAC)

Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non-hematological Cancer Treated With Intravenous Anti-tumor Therapy

Sponsor: Centre Hospitalier Régional Metz-Thionville

Conditions Catheter-Related Infections

Interventions Taurolock saline solution

Updated 5 times since 2017 Last updated: Aug 25, 2016 Started: Nov 30, 2014 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Catheter-Related Infections and is currently completed. Centre Hospitalier Régional Metz-Thionville leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Régional Metz-Thionville
Theradial
centre régional de pharmacovigilance de Nancy

Data source: Centre Hospitalier Régional Metz-Thionville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Metz, France